Novozymes AS (NZYM B):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Novozymes AS (NZYM B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9912
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Novozymes AS (Novozymes) is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment and bioinnovation solutions to minimize the CO2 emissions. Novozymes’s products also find applications in hand and automatic dishwashing soaps, laundry detergents and professional cleaning products among others. The company has operational presence in the countries of the Europe, Middle East and Africa, North America, Asia Pacific and Latin America regions. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS (NZYM B) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novozymes AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novozymes AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Novozymes AS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Paras Biopharma Enters into Agreement with Novozymes 10
Novozymes Biopharma Enters Into Agreement With Thiologics To Offer Drug-Albumin Conjugation Platform 11
Novozymes Biopharma Enters Into Research Agreement With EpiVax To Advance Treatment For Autoimmune Diseases 12
Licensing Agreements 13
yooyoung pharma Enters into Licensing Agreement with Novozymes 13
Epivax Enters into Licensing Agreement with Novozymes Biopharma 14
Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 15
Equity Offering 16
Albumedix Spin Off from Novozymes 16
Defensin Therapeutics Spin Out from Novozymes 17
Acquisition 18
Novozymes Acquires Organobalance 18
Novozymes AS – Key Competitors 19
Novozymes AS – Key Employees 20
Novozymes AS – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Affiliate 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Novozymes AS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novozymes AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novozymes AS, Deals By Therapy Area, 2012 to YTD 2018 8
Novozymes AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Paras Biopharma Enters into Agreement with Novozymes 10
Novozymes Biopharma Enters Into Agreement With Thiologics To Offer Drug-Albumin Conjugation Platform 11
Novozymes Biopharma Enters Into Research Agreement With EpiVax To Advance Treatment For Autoimmune Diseases 12
yooyoung pharma Enters into Licensing Agreement with Novozymes 13
Epivax Enters into Licensing Agreement with Novozymes Biopharma 14
Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 15
Albumedix Spin Off from Novozymes 16
Defensin Therapeutics Spin Out from Novozymes 17
Novozymes Acquires Organobalance 18
Novozymes AS, Key Competitors 19
Novozymes AS, Key Employees 20
Novozymes AS, Subsidiaries 21
Novozymes AS, Affiliate 23

List of Figures
Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Novozymes AS (NZYM B):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Precision NanoSystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision NanoSystems Inc (Precision NanoSystems) is a biopharmaceutical company that provides nanotechnology solutions to manufacture nanoparticles for molecular understanding and treatment of disease. The company offers products which include nanosystems, transfection kits for primary cell …
  • Vascular Biogenics Ltd (VBLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for ca …
  • SDX Energy Inc (SDX):石油・ガス:M&Aディール及び事業提携情報
    Summary SDX Energy Inc (SDX), formerly Sea Dragon Energy Inc., is an independent upstream company. It carries out the exploration, development and production of crude oil and natural gas liquids. The company’s primary areas of focus are Morocco and Egypt. Its principal operations are currently conce …
  • Ambuja Cements Limited:企業の戦略・SWOT・財務分析
    Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report Summary Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Repsol Sinopec Resources UK Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Repsol Sinopec Resources UK Ltd (Repsol Sinopec), formerly Talisman Sinopec Energy UK Ltd is an oil and gas company that offers exploration services. The company explores, discovers, and produces oil and gas across the North Sea. It provides operation in floating facilities, offshore platfor …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Virgin Atlantic Airways Ltd:企業の戦略・SWOT・財務分析
    Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report Summary Virgin Atlantic Airways Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • InTouch Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary InTouch Technologies Inc (InTouch Health) is a healthcare technology company that provides Telehealth Network, comprised of telehealth systems, clinical workflow solutions, software and managed services to healthcare systems and hospitals for the delivery of clinical care. The company’s tele …
  • Canadian Energy Services & Technology Corp (CEU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Energy Services & Technology Corp (CES) is a provider of chemical solutions. It provides technically advanced consumable chemical solutions for the North American oil and gas industry. The total solution provided by the company includes the drill-bit, at the point of completion and …
  • Dr. Reddy’s Research and Development BV-医療機器分野:企業M&A・提携分析
    Summary Dr. Reddy’s Research and Development BV (Dr. Reddy’s Research and Development), a subsidiary of Dr. Reddy's Laboratories Ltd is a drug formulation and manufacturing service provider that develops and manufactures improved injectable pharmaceuticals. The company offers services such as formul …
  • Ferrovie Dello Stato Italiane S.p.A.:企業の戦略的SWOT分析
    Ferrovie Dello Stato Italiane S.p.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Pepco Holdings LLC-エネルギー分野:企業M&A・提携分析
    Summary Pepco Holdings, LLC (Pepco Holdings), formerly Pepco Holdings, Inc., a subsidiary of Exelon Corporation, is a utility services holding company that transmits, distributes and supplies electricity through its subsidiaries. It also distributes and supplies natural gas. The company, through its …
  • Asiatravel.com Holdings Ltd:戦略・SWOT・企業財務分析
    Asiatravel.com Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Asiatravel.com Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PZ Cormay SA (CRM):医療機器:M&Aディール及び事業提携情報
    Summary PZ Cormay SA (Cormay) is a medical device company that produces and wholesale diagnostic reagents and laboratory equipment. The company provides products such as reagents, analyzers, coagulation, electrophoresis, urinalysis, rapid tests, assay sheets, and blood control instruments and equipm …
  • Saint-Gobain Weber GmbH:企業の戦略・SWOT・財務情報
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Universal Health Services Inc (UHS):企業の財務・戦略的SWOT分析
    Universal Health Services Inc (UHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bashneft (BANE)-石油・ガス分野:企業M&A・提携分析
    Summary Bashneft is a vertically integrated oil and gas company. It operates in the oil and gas production, refining, petrochemical production, marketing and distribution of oil and petroleum products. It sales crude oil, petroleum products and petrochemical products to the domestic market. The comp …
  • Ethicon US LLC:企業の戦略的SWOT分析
    Ethicon US LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Globin Solutions Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globin Solutions Inc (Globin) is a pre-clinical stage biotechnology company with focus on the research and development of antidotal medicines for human poisoning. Its lead compound, Ngb H64Q, an antidote, a mutant version of the protein neuroglobin, has been found to scavenge carbon monoxide …
  • Laval University:製薬・医療:M&Aディール及び事業提携情報
    Summary Laval University is an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate, degree programs and distance education programs. It offers courses in the fields of advanced international studies, agriculture and food scien …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆